202 related articles for article (PubMed ID: 15356213)
1. Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines.
Nikolaidis LA; Doverspike A; Hentosz T; Zourelias L; Shen YT; Elahi D; Shannon RP
J Pharmacol Exp Ther; 2005 Jan; 312(1):303-8. PubMed ID: 15356213
[TBL] [Abstract][Full Text] [Related]
2. A pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humans.
Read PA; Hoole SP; White PA; Khan FZ; O'Sullivan M; West NE; Dutka DP
Circ Cardiovasc Interv; 2011 Jun; 4(3):266-72. PubMed ID: 21586690
[TBL] [Abstract][Full Text] [Related]
3. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.
Nikolaidis LA; Mankad S; Sokos GG; Miske G; Shah A; Elahi D; Shannon RP
Circulation; 2004 Mar; 109(8):962-5. PubMed ID: 14981009
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
[TBL] [Abstract][Full Text] [Related]
6. Effect of transforming growth factor-beta 1 on myocardial stunning in the intact dog.
Sun JZ; Li XY; Sporn MB; Schneider MD; Roberts R; Bolli R
J Mol Cell Cardiol; 1993 Apr; 25(4):379-86. PubMed ID: 8340931
[TBL] [Abstract][Full Text] [Related]
7. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow.
Park SW; Tang XL; Qiu Y; Sun JZ; Bolli R
J Mol Cell Cardiol; 1996 Apr; 28(4):655-66. PubMed ID: 8732494
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
Zhao T; Parikh P; Bhashyam S; Bolukoglu H; Poornima I; Shen YT; Shannon RP
J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
[TBL] [Abstract][Full Text] [Related]
9. [N-2-mercaptopropionyl-glycine improves recovery of myocardial stunning after reversible regional ischemia in conscious dogs].
Li XY; Zughaib M; Sekili S; Bolli R
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 Feb; 13(1):32-5. PubMed ID: 10074307
[TBL] [Abstract][Full Text] [Related]
10. Effects of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin on myocardial dysfunction after a brief ischemia in anesthetized dogs.
Chang TH; Adachi H; Okuyama T; Zhang KY
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):388-91. PubMed ID: 7717058
[TBL] [Abstract][Full Text] [Related]
11. [Effects of insulin on cardiac function and coronary circulation in acute myocardial ischemia and reperfusion experiment with dogs].
Ma H; Huo JH; Zhang HX; Bian JF; Wang YM; Xiong LZ; Guo WY; Wang HC; Gao F
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3128-32. PubMed ID: 17313765
[TBL] [Abstract][Full Text] [Related]
12. Effects of gadolinium on regionally stunned myocardium: temporal considerations.
Nicolosi AC; Kwok CS; Logan B
J Surg Res; 2007 May; 139(2):286-91. PubMed ID: 17270216
[TBL] [Abstract][Full Text] [Related]
13. Rapid ventricular pacing induces delayed cardioprotection against myocardial stunning.
Lucats L; Chalvignac V; Bizé A; Monnet X; Zini R; Hittinger L; Berdeaux A; Ghaleh B
J Mol Cell Cardiol; 2005 Dec; 39(6):849-55. PubMed ID: 16242141
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents.
Dokken BB; La Bonte LR; Davis-Gorman G; Teachey MK; Seaver N; McDonagh PF
Horm Metab Res; 2011 May; 43(5):300-5. PubMed ID: 21360419
[TBL] [Abstract][Full Text] [Related]
15. Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs.
Takahashi T; Takahashi K; Onishi M; Suzuki T; Tanaka Y; Ota T; Yoshida S; Nakaike S; Matsuda T; Baba A
Eur J Pharmacol; 2004 Nov; 505(1-3):163-8. PubMed ID: 15556149
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of trimetazidine in ischemia-reperfusion lesion. Experimental study in myocardial stunning model].
Morillas P; Hernández A; Pallarés V; Bertomeu V; Roldán FJ; Capdevilla C; Azorín I; Aguilar A; Portolés M; Cosín J
Arch Cardiol Mex; 2004; 74(4):262-70. PubMed ID: 15709502
[TBL] [Abstract][Full Text] [Related]
17. Effect of adenosine on myocardial 'stunning' in the dog.
Sekili S; Jeroudi MO; Tang XL; Zughaib M; Sun JZ; Bolli R
Circ Res; 1995 Jan; 76(1):82-94. PubMed ID: 8001281
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
Nauck MA
Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization.
McCormick LM; Hoole SP; White PA; Read PA; Axell RG; Clarke SJ; O'Sullivan M; West NEJ; Dutka DP
JACC Cardiovasc Interv; 2015 Feb; 8(2):292-301. PubMed ID: 25700752
[TBL] [Abstract][Full Text] [Related]
20. Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting.
Sokos GG; Bolukoglu H; German J; Hentosz T; Magovern GJ; Maher TD; Dean DA; Bailey SH; Marrone G; Benckart DH; Elahi D; Shannon RP
Am J Cardiol; 2007 Sep; 100(5):824-9. PubMed ID: 17719327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
